Showing results (111-120 of 315) with videos related to

Sort By:
Pageof 32
Revista Espanola De Enfermedades Digestivas|November 6, 2023
Triangle Tip-Jet Knife used as "probe mode" can reduce the risk of mucosal damage during incision and tunneling phase of peroral endoscopic myotomy (POEM) proceduresMiguel Fraile López, Álvaro Terán, Pedro Luis Fernández Gil, et al.
Scientific Reports|November 16, 2019
Improved Health Outcomes from Hepatitis C Treatment Scale-Up in Spain's Prisons: A Cost-Effectiveness StudyOzden O Dalgic, Sumeyye Samur, Anne C Spaulding, et al.
Revista Espanola De Enfermedades Digestivas|May 26, 2025
Calcitonin gene-related peptide (CGRP) in the pathophysiology of gastrointestinal disorders - A key mediator in the gut-brain axisMarta Pascual-Mato, Gabriel Gárate Viñas, María Muñoz San Martín, et al.
Revista Espanola De Enfermedades Digestivas|August 31, 2022
Current state of telemedicine in the field of Hepatology in Spain: challenges, threats and next steps to follow for an intelligent digital transformationJavier Crespo, Joaquín Cabezas, Miguel Mateo Soler, et al.
International Journal of Molecular Sciences|April 17, 2019
LOXL2-A New Target in Antifibrogenic Therapy?Angela Puente, Jose Ignacio Fortea, Joaquin Cabezas, et al.
Journal of Clinical Medicine|May 13, 2026
MASLD Management in Spain: A Nationwide Survey of Gastroenterologists Highlighting Gaps in Risk Assessment and Primary Care CoordinationCarolina Jiménez-González, Paula Argos Vélez, Lorena Cayón, et al.
Transplantation Proceedings|January 4, 2025
SARS-CoV-2 Infection and Liver Transplant: How Are We Now?Carlos Gutiérrez García, Antonio Cuadrado, José Ignacio Fortea, et al.
Revista Espanola De Enfermedades Digestivas|December 20, 2016
Influence of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with antiviral triple therapyÁngela Puente, Joaquín Cabezas, María Jesús López Arias, et al.
Hepatology (Baltimore, Md.)|March 4, 2014
Computerized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents: the PRESCRIB projectBlanca Sampedro, Cándido Hernández-López, José Ramón Ferrandiz, et al.
Clinical Reviews in Allergy & Immunology|January 25, 2013
Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel diseaseMaria Teresa Arias-Loste, Geovana Bonilla, Irene Moraleja, et al.
Pageof 32